Phenomex stock.

The Functional Cell Biology Company. Bruker Cellular Analysis is empowering scientists to leverage the full potential of each cell and drive the next era of functional cell biology to advance human health. We enable scientists to reveal the most complete insights on cell function and obtain a full view of the behavior of each cell.

Phenomex stock. Things To Know About Phenomex stock.

Discover historical prices for CELL stock on Yahoo Finance. View daily, weekly or monthly format back to when PhenomeX Inc. stock was issued.--PhenomeX, the functional cell biology company, today announced that it will participate in the 19 th annual Protein Engineering& Cell Therapy Summit Conference and Expo being held from May 15-19 ...PhenomeX Inc. Condensed Consolidated Balance Sheets (Unaudited) M arc h 31, 2023 D e c e m b e r 31, ( I n t h ou s an d s , e xc e p t s h are an d p e r s h are d at a) 2022 A s s e t s C ur r e nt a s s e t s : C a s h a nd c a s h e qui va l e nt s $ 51,606 $ 86,522 S hor t - t e r m m a r ke t a bl e s e c ur i t i e s — 46,252(A) Strategies for helix structure nucleation with i and i+4 crosslinking using metal complexation (top) or double click cycloaddition (bottom). a Di-azidoalanine peptide was treated in aqueous buffer with bis alkynes 6–9, sodium ascorbate, CuSO 4, and bathophenanthroline disulfonic acid or on resin in DMF with CuI and DIEA.(B) Peptide …Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.

Historical daily share price chart and data for PhenomeX Inc. from 2020 to 2023 adjusted for splits and dividends. CELL was delisted after September 29, 2023. The latest closing stock price for PhenomeX Inc. on September 29, 2023 is 1.00. The all-time high PhenomeX Inc. closing stock price was 106.00 on December 22, 2020. ZebronZB-5MS PLUS. Better Peak Shape, Low Bleed, and Aqueous Stability for specialty chemical, forensic, toxicology, and food testing applications. Leading Manufacturer of HPLC Columns, GC columns, Sample Prep Products, and …PhenomeX was formed earlier this year when cell analysis firm Berkeley Lights closed its acquisition of proteomics firm IsoPlexis for $57.8 million in stock. In Q1, the firm reported revenues of $18.5 million, down 8 percent year over year.

PhenomeX will host a conference call to discuss the first quarter 2023 financial results after market close on Thursday, May 11, 2023 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

May 11, 2023 · PhenomeX, Inc. (Nasdaq: CELL), a life sciences tools company, today reported financial results for the first quarter ended March 31, 2023. Following the completion of Berkeley Lights' acquisition ... BILLERICA, Mass. & EMERYVILLE, Calif., August 17, 2023--Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today announced that they have signed a definitive agreement for Bruker...BILLERICA, Mass. & EMERYVILLE, Calif., August 17, 2023--Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today announced that they have signed a definitive agreement for Bruker...Aug 17, 2023 · BILLERICA, Mass. & EMERYVILLE, Calif.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today announced that they have signed a definitive agreement for Bruker ...

Berkeley Lights (Nasdaq: BLI) and IsoPlexis (Nasdaq: ISO) today announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million.

May 11, 2023 · EMERYVILLE, Calif., May 11, 2023 /PRNewswire/ -- PhenomeX (Nasdaq: CELL), the functional cell biology company, today announced that it will participate in the 19 th annual Protein Engineering ...

EMERYVILLE, Calif., Nov. 8, 2022 /PRNewswire/ -- Berkeley Lights, Inc. , a leader in digital cell biology, today reported financial results for the quarter ended ...Historical daily share price chart and data for PhenomeX Inc. from 2020 to 2023 adjusted for splits and dividends. CELL was delisted after September 29, 2023. The latest closing stock price for PhenomeX Inc. on September 29, 2023 is 1.00. The all-time high PhenomeX Inc. closing stock price was 106.00 on December 22, 2020.17 brokerages have issued 12 month target prices for Danaher's stock. Their DHR share price targets range from $215.00 to $320.00. On average, they expect the company's stock price to reach $257.73 in the next year. This suggests a possible upside of 16.5% from the stock's current price.Credit: Arek Socha from Pixabay. Bruker has entered a definitive agreement to acquire functional cell biology company PhenomeX for a total equity value of $108m. The company will initiate a tender offer to purchase all of PhenomeX’s outstanding shares for $1.00 per share, payable in cash. PhenomeX offers single-cell biology research tools for ...Item 2.02. Results of Operations and Financial Condition On November 4, 2021, Berkeley Lights, Inc. issued a press release announcing the Company's financial results for the quarter ended September... | March 25, 2023

Historical daily share price chart and data for PhenomeX Inc. from 2020 to 2023 adjusted for splits and dividends. CELL was delisted after September 29, 2023. The latest closing stock price for PhenomeX Inc. on September 29, 2023 is 1.00. The all-time high PhenomeX Inc. closing stock price was 106.00 on December 22, 2020.Bird Mergersub Corporation, a Delaware corporation (“Purchaser”) and a wholly owned subsidiary of Bruker Corporation, a Delaware corporation (“Bruker”), is offering to purchase all of the outstanding shares of common stock, par value $0.00005 per share (the “Shares”), of PhenomeX Inc., a Delaware corporation (“PhenomeX”), for $1.00 per Share, net to the seller in cash, without ... Feb 23, 2023 · Recent Highlights. Achieved revenue of $78.6 million for the full year 2022, representing an 8% decrease over the prior year;; Announced the acquisition agreement of IsoPlexis to create a premier functional cell biology company, PhenomeX, when the merger closes, would accelerate the transformation of Berkeley Lights from a technology platform company into a growing, profitable, and sustainable ... Berkeley Lights, Inc. recently announced the acquisition of IsoPlexis for $57.8 million in an all-stock deal. It will change the combined company name to PhenomeX. It will change the combined ...EMERYVILLE, Calif., May 09, 2022 -- Berkeley Lights, Inc. , a leader in digital cell biology, today reported financial results for the quarter ended March 31, 2022. Recent Highlights ...

PhenomeX Inc (CELL). Sector: HEALTH CARE. Industry: BIOTECHNOLOGY & LIFE SCIENCES. SIC: LABORATORY ANALYTICAL ... Stock Lookup. Enter stock name: use * for ...The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to ...

PhenomeX Inc. Condensed Consolidated Balance Sheets (Unaudited) M arc h 31, 2023 D e c e m b e r 31, ( I n t h ou s an d s , e xc e p t s h are an d p e r s h are d at a) 2022 A s s e t s C ur r e nt a s s e t s : C a s h a nd c a s h e qui va l e nt s $ 51,606 $ 86,522 S hor t - t e r m m a r ke t a bl e s e c ur i t i e s — 46,252The fair value is based on 24,945,611 shares of PhenomeX common stock at $ 1.28 per share on March 21, 2023 issued to IsoPlexis stockholders. IsoPlexis stockholders received 0.612 shares of PhenomeX stock for …PhenomeX Inc (CELL). Sector: HEALTH CARE. Industry: BIOTECHNOLOGY & LIFE SCIENCES. SIC: LABORATORY ANALYTICAL ... Stock Lookup. Enter stock name: use * for ...The fair value is based on 24,945,611 shares of PhenomeX common stock at $ 1.28 per share on March 21, 2023 issued to IsoPlexis stockholders. IsoPlexis stockholders received 0.612 shares of PhenomeX stock for …We would like to show you a description here but the site won’t allow us.Sep 29, 2023 · PhenomeX Inc. (BLI.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock PhenomeX Inc. | Nyse: BLI | Nyse A high-level overview of PhenomeX Inc. (CELL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.WebAll Outstanding Shares of Common Stock . of . PHENOMEX INC. at $1.00 per share, net in cash, without interest . Pursuant to the Offer to Purchase dated August 31, 2023 . by . BIRD MERGERSUB CORPORATION . a wholly-owned subsidiary . of . BRUKER CORPORATIONTipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com

PhenomeX Inc. Condensed Consolidated Balance Sheets (Unaudited) M arc h 31, 2023 D e c e m b e r 31, ( I n t h ou s an d s , e xc e p t s h are an d p e r s h are d at a) 2022 A s s e t s C ur r e nt a s s e t s : C a s h a nd c a s h e qui va l e nt s $ 51,606 $ 86,522 S hor t - t e r m m a r ke t a bl e s e c ur i t i e s — 46,252

Mar 21, 2023 · PhenomeX (Nasdaq: CELL), the functional cell biology company, today announced that Yan Zhang, Ph.D., has been named chief commercial officer (CCO), effective immediately. In addition to Dr. Zhang ...

PhenomeX (Nasdaq: CELL), the functional cell biology company, today announced that Yan Zhang, Ph.D., has been named chief commercial officer (CCO), effective immediately. In addition to Dr. Zhang ...Aug 17, 2023 · Acquisition initiates Bruker’s entry into functional single-cell biology research solutions. BILLERICA, Mass. & EMERYVILLE, Calif.--(BUSINESS WIRE)--#BRKR--Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today announced that they have signed a definitive agreement for Bruker to acquire PhenomeX for $1.00 per share in an all-cash transaction. PhenomeX Inc. (CELL) stock has more than doubled on Thursday after Bruker Corp. (BRKR) said it would acquire the Emeryville, Calif.-based, cell biology …WebHistorical daily share price chart and data for PhenomeX Inc. from 2020 to 2023 adjusted for splits and dividends. CELL was delisted after September 29, 2023. The latest closing stock price for PhenomeX Inc. on September 29, 2023 is 1.00. The all-time high PhenomeX Inc. closing stock price was 106.00 on December 22, 2020.PhenomeX Inc. (CELL) delivered earnings and revenue surprises of -11.11% and 3.52%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?13 sept 2023 ... PhenomeX Inc. (CELL) Common Shares. Quantity: All PhenomeX Inc. (CELL) Common Shares. Price: $1.00 net cash per share. Expiration: One minute ...Convert PhenomeX Inc. stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock. apple; wise; Select a currency. USD. NASDAQ: PhenomeX Inc. (CELL) = 1.00 USD. Provided by Alpha Vantage. PhenomeX Inc. stock (CELL) in USD. 1 CELL = 1.00 USD. 1 month.Oct 3, 2023 · During its Q3 2023 earnings release, Bruker will provide more details on the expected Q4 2023 effect from PhenomeX. Today, Bruker reconfirms its medium-term financial outlook as issued at its Investor Day in June 2023. As a result of the transaction closing, PhenomeX common stock will no longer be listed for trading on the Nasdaq Global Market.

Dec 22, 2022 · Berkeley Lights (Nasdaq: BLI), a life sciences tools company, and IsoPlexis (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million. -- Berkeley Lights and biotech start-up Aanika Biosciences said Monday they are working together to improve food safety, enable faster identification of outbreak sources and minimize the impact of...The Functional Cell Biology Company. Bruker Cellular Analysis is empowering scientists to leverage the full potential of each cell and drive the next era of functional cell biology to advance human health. We enable scientists to reveal the most complete insights on cell function and obtain a full view of the behavior of each cell.Instagram:https://instagram. tdd stock3 month treasury notevfsaxdo you need insurance for chiropractor The Functional Cell Biology Company. Bruker Cellular Analysis is empowering scientists to leverage the full potential of each cell and drive the next era of functional cell biology to advance human health. We enable scientists to reveal the most complete insights on cell function and obtain a full view of the behavior of each cell.The fair value is based on 24,945,611 shares of PhenomeX common stock at $ 1.28 per share on March 21, 2023 issued to IsoPlexis stockholders. IsoPlexis stockholders received 0.612 shares of PhenomeX stock for each IsoPlexis share they held. (2) ... live cattle futures charttesla battery company stock CELL Stock 12 Months Forecast. Based on 5 Wall Street analysts offering 12 month price targets for PhenomeX in the last 3 months. The average price target is $1.00 with a high forecast of $1.00 and a low forecast of $1.00. The average price target represents a 0.19% change from the last price of $1.00. fidelity total international index fund What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...Historical daily share price chart and data for PhenomeX Inc. from 2020 to 2023 adjusted for splits and dividends. CELL was delisted after September 29, 2023. The latest closing stock price for PhenomeX Inc. on September 29, 2023 is 1.00. The all-time high PhenomeX Inc. closing stock price was 106.00 on December 22, 2020. Real time PhenomeX (BLI) stock price quote, stock graph, news & analysis.